Literature DB >> 12752467

A retrospective analysis of hippocampal pathology in human temporal lobe epilepsy: evidence for distinctive patient subcategories.

Nihal C de Lanerolle1, Jung H Kim, Anne Williamson, Susan S Spencer, Hitten P Zaveri, Tore Eid, Dennis D Spencer, Toye Eid.   

Abstract

PURPOSE: This study is a retrospective analysis of the pathology of the hippocampus from patients with medically intractable temporal lobe epilepsy. We attempted to relate neuronal density, immunohistochemistry, electrophysiologic data, and surgical outcome.
METHODS: Immunostaining patterns for neuropeptide Y, somatostatin, substance P, and dynorphin defined the immunohistochemical characteristics of the hippocampi. Neuronal densities were determined by microscopic cell counts. Sharp electrode recordings from dentate granule cells determined measures of inhibition and excitation.
RESULTS: Patient hippocampi without evidence of sclerosis generally resembled autopsy controls on the basis of neuronal densities of hippocampal subfields and patterns of immunostaining. The nonsclerotic hippocampi were divisible into two subgroups on the basis of neuronal density correlations between hippocampal subfields, the excitability of dentate granule cells, etiology, and surgical outcome. Hippocampi with sclerosis were divisible into those with significant neuronal loss confined to area CA1 and those with neuronal loss throughout the hippocampus and dentate gyrus. In the former, the dentate gyrus resembled in morphology the nonsclerotic hippocampi but with slightly increased excitability of the dentate granule cells. The hippocampi with more extensive neuronal loss had changes in immunostaining patterns associated with the dentate gyrus, correlated with significant hyperexcitability of dentate granule cells. The surgical outcome, with the exception of one group, was good in approximately 70-90%.
CONCLUSIONS: Hippocampi from patients with intractable temporal lobe epilepsy can be assigned to several groups on the basis of pathophysiology. Different pathologies may represent differing causative mechanisms of intractable temporal lobe epilepsy and be predictive of surgical outcome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12752467     DOI: 10.1046/j.1528-1157.2003.32701.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  70 in total

Review 1.  Astrocytic regulation of glutamate homeostasis in epilepsy.

Authors:  Douglas A Coulter; Tore Eid
Journal:  Glia       Date:  2012-05-16       Impact factor: 7.452

2.  Is mesial temporal sclerosis a necessary component of temporal lobe epilepsy?

Authors:  Jaideep Kapur
Journal:  Epilepsy Curr       Date:  2006 Nov-Dec       Impact factor: 7.500

3.  Geschwind Syndrome in frontotemporal lobar degeneration: Neuroanatomical and neuropsychological features over 9 years.

Authors:  Laura Veronelli; Sara J Makaretz; Megan Quimby; Bradford C Dickerson; Jessica A Collins
Journal:  Cortex       Date:  2017-06-27       Impact factor: 4.027

Review 4.  Mesial temporal lobe epilepsy: How do we improve surgical outcome?

Authors:  Maria Thom; Gary W Mathern; J Helen Cross; Edward H Bertram
Journal:  Ann Neurol       Date:  2010-10       Impact factor: 10.422

Review 5.  Slit-Robo interactions during cortical development.

Authors:  William D Andrews; Melissa Barber; John G Parnavelas
Journal:  J Anat       Date:  2007-06-06       Impact factor: 2.610

Review 6.  30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.

Authors:  Christoph Schwarzer
Journal:  Pharmacol Ther       Date:  2009-05-28       Impact factor: 12.310

7.  Effects of Branched-Chain Amino Acid Supplementation on Spontaneous Seizures and Neuronal Viability in a Model of Mesial Temporal Lobe Epilepsy.

Authors:  Shaun E Gruenbaum; Roni Dhaher; Amedeo Rapuano; Hitten P Zaveri; Amber Tang; Nihal de Lanerolle; Tore Eid
Journal:  J Neurosurg Anesthesiol       Date:  2019-04       Impact factor: 3.956

8.  Loss of perivascular Kir4.1 potassium channels in the sclerotic hippocampus of patients with mesial temporal lobe epilepsy.

Authors:  Kjell Heuser; Tore Eid; Fredrik Lauritzen; Anna E Thoren; Gry F Vindedal; Erik Taubøll; Leif Gjerstad; Dennis D Spencer; Ole P Ottersen; Erlend A Nagelhus; Nihal C de Lanerolle
Journal:  J Neuropathol Exp Neurol       Date:  2012-09       Impact factor: 3.685

9.  Gene expression of glutamate metabolizing enzymes in the hippocampal formation in human temporal lobe epilepsy.

Authors:  Tore Eid; Tih-Shih W Lee; Yue Wang; Edgar Perez; Edgar Peréz; Jana Drummond; Fredrik Lauritzen; Linda H Bergersen; James H Meador-Woodruff; Dennis D Spencer; Nihal C de Lanerolle; Robert E McCullumsmith
Journal:  Epilepsia       Date:  2012-11-13       Impact factor: 5.864

10.  Recurrent seizures and brain pathology after inhibition of glutamine synthetase in the hippocampus in rats.

Authors:  Tore Eid; Arko Ghosh; Yue Wang; Henning Beckström; Hitten P Zaveri; Tih-Shih W Lee; James C K Lai; Gauri H Malthankar-Phatak; Nihal C de Lanerolle
Journal:  Brain       Date:  2008-07-06       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.